| New cancer drug could aid thousands
Thousands of patients suffering breast and prostate cancer could benefit from a new drug, experts have said. Cancers such as breast and prostate are often fuelled by sex hormones, including oestrogen or testosterone. Many patients can benefit from hormone therapies aimed at cutting levels of these hormones, thereby "starving" the cancer and halting tumour growth. But some people have cancers that are resistant to such treatments while others build up a resistance to the hormone drugs. Such "hormone-independent" cancer cells are a major challenge to treat and current therapies are limited. Now a study by researchers at Imperial College London, published in the British Journal of Cancer, has revealed promising results for a new drug, STX140.
Scientists Develop New Drug To Outflank Cancer Resistance, UK
A new drug has shown promising results against breast and prostate cancer cells and tumours that are resistant to conventional hormone-based treatments, according to research published in the British Journal of Cancer.
Cancers such as breast and prostate cancer are often fuelled by sex hormones, such as oestrogen or testosterone. Hormone therapy for breast or prostate cancer aims to reduce the levels of these hormones in the body, "starving" the cancer of these signals and halting tumour growth. Some cancers are resistant to this treatment from the outset while many build up a resistance to these drugs over time, their growth becoming hormone-independent - such cancers are a major challenge to treat.
Now, researchers have shown that a new drug - STX140 - directly targets hormone-independent cancer cells by initiating a natural suicide process within them.
Public Health & Education | Low-Fat Diets Reduce Risk of Ovarian ...
An abstract of the study is available online. Most Women Unaware of WHI Results, Survey Says
Most women are unaware of the results from WHI studies that have found significant health risks associated with long-term hormone replacement therapy, according to a recently released survey, HealthDay/Washington Post reports (Doheny, HealthDay/Washington Post, 10/10).
NIH researchers in July 2002 ended the WHI study on combination HRT three years early because they determined that the treatment might increase the risk for heart disease, invasive breast cancer and other health problems. A later WHI analysis, published in the April 4 issue of the Journal of the American Medical Association, found that HRT use among women in their 50s does not increase their risk for heart attack (Kaiser Daily Women's Health Policy Report, 9/17).
LOCAL COLUMN: Ready to face tomorrow?
He practiced medicine here in Meadville for more than half a century. My Uncle Ed was a dentist. He walked to school and completed the eighth grade, then worked as a streetcar conductor before fighting in the Spanish American War. Afterward, he attended University of Pittsburgh Dental School, graduating in 1904. When my mother first became a legal secretary (she walked to school, too) she worked for an attorney who shared office space with a lawyer named Captain Jimmy Smith. Captain Smith was a Civil War veteran who never went to college or law school. As a kid, he probably walked to school. But as a young man, he "read law" in the offices of another lawyer and ultimately gained enough experience to hang out his shingle without the benefit of a long, expensive education. Those were simpler times.
PET/CT Brings New Hope To Patients With Deadly Form Of Breast Cancer
ScienceDaily (Dec. 2, 2007) Researchers are improving the chances of women faced with an aggressive and difficult to diagnose form of breast cancer. Inflammatory breast cancer spreads quickly and can be lethal in six to nine months. But by using fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG-PET/CT), radiologists and physicists are able to spot the spread of cancer earlier, according to a study presented November 26 at the annual meeting of the Radiological Society of North America. .
Kalel's Thought Bubble
Someone asked me what my take was on TO. I had never shared my thoughts on him before but I went on and shared my humble opinion. Steve Mariucci, Jeff Garcia and Donovan McNabb should be writing checks to this guy. They owe him huge! Remember when JEFF GARCIA was a pro bowl QB???? I do, it happens to coincide with Terrell Owens being on his team. Garcia ended up parlaying his 3 pro bowl appearances into a nice fat contract with the Browns. After a sub par season with the Browns he ended up in Detroit splitting time with Joey Harrington. Never again looking anything like the "pro bowl" qb he was in San Fran. Actually, Garcia owns a 4-13 record as a starter since he and TO parted ways. Meanwhile TO has a 17-5 record over the same period with the Eagles. Remember when Steve Mariucci was the second coming of Bill Walsh? I do, It happens to coincide with the TO era in San Francisco.
|
